Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. A potential etiologic role for immune dysfunction in ASD has been suggested. Dynamic adaptive cellular immune function was investigated in 66 children with a confirmed diagnosis of ASD and 73 confirmed typically developing (TD) controls 2-5 yearsof-age. In vitro stimulation of peripheral blood mononuclear cells with PHA and tetanus was used to compare group-associated cellular responses. The production of GM-CSF, TNFa, and IL-13 were significantly increased whereas IL-12p40 was decreased following PHA stimulation in ASD relative to TD controls. Induced cytokine production was associated with altered behaviors in ASD children such that increased pro-inflammatory or T H 1 cytokines were associated with greater impairments in core features of ASD as well as aberrant behaviors. In contrast, production of GM-CSF and T H 2 cytokines were associated with better cognitive and adaptive function. Following stimulation, the frequency of CD3 + , CD4
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b s t r a c t
Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. A potential etiologic role for immune dysfunction in ASD has been suggested. Dynamic adaptive cellular immune function was investigated in 66 children with a confirmed diagnosis of ASD and 73 confirmed typically developing (TD) controls 2-5 yearsof-age. In vitro stimulation of peripheral blood mononuclear cells with PHA and tetanus was used to compare group-associated cellular responses. The production of GM-CSF, TNFa, and IL-13 were significantly increased whereas IL-12p40 was decreased following PHA stimulation in ASD relative to TD controls. Induced cytokine production was associated with altered behaviors in ASD children such that increased pro-inflammatory or T H 1 cytokines were associated with greater impairments in core features of ASD as well as aberrant behaviors. In contrast, production of GM-CSF and T H 2 cytokines were associated with better cognitive and adaptive function. Following stimulation, the frequency of CD3 + , CD4
+ and CD8 + T cells expressing activation markers CD134 and CD25 but not CD69, HLA-DR or CD137 were significantly reduced in ASD, and suggests an altered activation profile for T cells in ASD. Overall these data indicate significantly altered adaptive cellular immune function in children with ASD that may reflect dysfunctional immune activation, along with evidence that these perturbations may be linked to disturbances in behavior and developmental functioning. Further longitudinal analyzes of cellular immunity profiles would delineate the relationship between immune dysfunction and the progression of behavioral and developmental changes throughout the course of this disorder. Ó 2010 Elsevier Inc. All rights reserved.
Introduction
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders that include autistic disorder, Asperger's disorder and pervasive developmental disorder, not otherwise specified (APA, 2000) . Children with ASD have significant deficits in communication and social interactions and exhibit stereotyped or restricted behaviors and interests. Recent epidemiologic data suggest that approximately 1 in 100 children are diagnosed with an ASD (MMWR, 2009) . The etiology of autism is complex and largely unknown, although it is highly heritable. While many studies yield evidence that there are genes that strongly impact the likelihood of developing autism, no definitive pattern of genes has been identified despite a multitude of different and varied candidate genes that have been implicated in ASD (Muhle et al., 2004) . Moreover, replication of these data has been inconsistent; probably due in part to the heterogeneity of the phenotypes within the autism spectrum. However, among the potential genetic candidates several studies have linked ASD with immune-based genes, such as human leukocyte antigen (HLA)-DRB1 * 04, interleukin (IL)-4 receptor, and complement C4B null allele (Lee et al., 2006; Torres et al., 2006; Warren et al., 1992 Warren et al., , 1995 , as well as a number of other immune-related genes including macrophage migration inhibitory factor (MIF) (Grigorenko et al., 2008) , MET tyrosine receptors (Campbell et al., 2006 (Campbell et al., , 2007 Garbett et al., 2008) 
